img

Global Respiratory Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Respiratory Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Respiratory drug is a term used to describe a wide variety of medicines used to relieve, treat, or prevent respiratory diseases such as asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), or pneumonia.
Respiratory Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Respiratory Drug market is projected to reach US$ 64160 million in 2034, increasing from US$ 43040 million in 2022, with the CAGR of 5.8% during the period of 2024 to 2034. Demand from Hospital and Drugs Store are the major drivers for the industry.
The classification of Respiratory Drug includes Inhalable & Nasal Spray, Oral and Others, and the proportion of Inhalable & Nasal Spray in 2019 is about 68.82%.
Respiratory Drug widely sold through Hospital and Drugs Store. The most proportion of Respiratory Drug sold through Drugs Store, and the proportion in 2019 is 58.28%.
North America is the largest consumption place, with a consumption market share nearly 35.24% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 28.58%. Moreover, the Asian market is expected to register the highest CAGR during the forecast period.
Market competition is intense. GSK, AstraZeneca, Boehringer Ingelheim, Vertex, Roche, etc. are the leaders of the industry.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Respiratory Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GSK
AstraZeneca
Boehringer Ingelheim
Vertex
Roche
Novartis
Teva
Chiesi
Mylan
Sumitomo Dainippon
Merck
Beximco
Segment by Type
Inhalable & Nasal Spray
Oral
Others

Segment by Application


Hospital
Drugs Store

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Respiratory Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Respiratory Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Respiratory Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Respiratory Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Respiratory Drug introduction, etc. Respiratory Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Respiratory Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Respiratory Drug Market Overview
1.1 Respiratory Drug Product Overview
1.2 Respiratory Drug Market Segment by Type
1.2.1 Inhalable & Nasal Spray
1.2.2 Oral
1.2.3 Others
1.3 Global Respiratory Drug Market Size by Type
1.3.1 Global Respiratory Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Respiratory Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Respiratory Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Respiratory Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Respiratory Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Respiratory Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Respiratory Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Respiratory Drug Sales Breakdown by Type (2018-2024)
2 Global Respiratory Drug Market Competition by Company
2.1 Global Top Players by Respiratory Drug Sales (2018-2024)
2.2 Global Top Players by Respiratory Drug Revenue (2018-2024)
2.3 Global Top Players by Respiratory Drug Price (2018-2024)
2.4 Global Top Manufacturers Respiratory Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Respiratory Drug Market Competitive Situation and Trends
2.5.1 Respiratory Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Respiratory Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Respiratory Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Respiratory Drug Market
2.8 Key Manufacturers Respiratory Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Respiratory Drug Status and Outlook by Region
3.1 Global Respiratory Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Respiratory Drug Historic Market Size by Region
3.2.1 Global Respiratory Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Respiratory Drug Sales in Value by Region (2018-2024)
3.2.3 Global Respiratory Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Respiratory Drug Forecasted Market Size by Region
3.3.1 Global Respiratory Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Respiratory Drug Sales in Value by Region (2024-2034)
3.3.3 Global Respiratory Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Respiratory Drug by Application
4.1 Respiratory Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Drugs Store
4.2 Global Respiratory Drug Market Size by Application
4.2.1 Global Respiratory Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Respiratory Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Respiratory Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Respiratory Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Respiratory Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Respiratory Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Respiratory Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Respiratory Drug Sales Breakdown by Application (2018-2024)
5 North America Respiratory Drug by Country
5.1 North America Respiratory Drug Historic Market Size by Country
5.1.1 North America Respiratory Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Respiratory Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Respiratory Drug Sales in Value by Country (2018-2024)
5.2 North America Respiratory Drug Forecasted Market Size by Country
5.2.1 North America Respiratory Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Respiratory Drug Sales in Value by Country (2024-2034)
6 Europe Respiratory Drug by Country
6.1 Europe Respiratory Drug Historic Market Size by Country
6.1.1 Europe Respiratory Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Respiratory Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Respiratory Drug Sales in Value by Country (2018-2024)
6.2 Europe Respiratory Drug Forecasted Market Size by Country
6.2.1 Europe Respiratory Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Respiratory Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Respiratory Drug by Region
7.1 Asia-Pacific Respiratory Drug Historic Market Size by Region
7.1.1 Asia-Pacific Respiratory Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Respiratory Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Respiratory Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Respiratory Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Respiratory Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Respiratory Drug Sales in Value by Region (2024-2034)
8 Latin America Respiratory Drug by Country
8.1 Latin America Respiratory Drug Historic Market Size by Country
8.1.1 Latin America Respiratory Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Respiratory Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Respiratory Drug Sales in Value by Country (2018-2024)
8.2 Latin America Respiratory Drug Forecasted Market Size by Country
8.2.1 Latin America Respiratory Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Respiratory Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Respiratory Drug by Country
9.1 Middle East and Africa Respiratory Drug Historic Market Size by Country
9.1.1 Middle East and Africa Respiratory Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Respiratory Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Respiratory Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Respiratory Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Respiratory Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Respiratory Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Respiratory Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 GSK Respiratory Drug Products Offered
10.1.5 GSK Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information
10.2.2 AstraZeneca Introduction and Business Overview
10.2.3 AstraZeneca Respiratory Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 AstraZeneca Respiratory Drug Products Offered
10.2.5 AstraZeneca Recent Development
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Information
10.3.2 Boehringer Ingelheim Introduction and Business Overview
10.3.3 Boehringer Ingelheim Respiratory Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Boehringer Ingelheim Respiratory Drug Products Offered
10.3.5 Boehringer Ingelheim Recent Development
10.4 Vertex
10.4.1 Vertex Company Information
10.4.2 Vertex Introduction and Business Overview
10.4.3 Vertex Respiratory Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Vertex Respiratory Drug Products Offered
10.4.5 Vertex Recent Development
10.5 Roche
10.5.1 Roche Company Information
10.5.2 Roche Introduction and Business Overview
10.5.3 Roche Respiratory Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Roche Respiratory Drug Products Offered
10.5.5 Roche Recent Development
10.6 Novartis
10.6.1 Novartis Company Information
10.6.2 Novartis Introduction and Business Overview
10.6.3 Novartis Respiratory Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Novartis Respiratory Drug Products Offered
10.6.5 Novartis Recent Development
10.7 Teva
10.7.1 Teva Company Information
10.7.2 Teva Introduction and Business Overview
10.7.3 Teva Respiratory Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Teva Respiratory Drug Products Offered
10.7.5 Teva Recent Development
10.8 Chiesi
10.8.1 Chiesi Company Information
10.8.2 Chiesi Introduction and Business Overview
10.8.3 Chiesi Respiratory Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Chiesi Respiratory Drug Products Offered
10.8.5 Chiesi Recent Development
10.9 Mylan
10.9.1 Mylan Company Information
10.9.2 Mylan Introduction and Business Overview
10.9.3 Mylan Respiratory Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Mylan Respiratory Drug Products Offered
10.9.5 Mylan Recent Development
10.10 Sumitomo Dainippon
10.10.1 Sumitomo Dainippon Company Information
10.10.2 Sumitomo Dainippon Introduction and Business Overview
10.10.3 Sumitomo Dainippon Respiratory Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Sumitomo Dainippon Respiratory Drug Products Offered
10.10.5 Sumitomo Dainippon Recent Development
10.11 Merck
10.11.1 Merck Company Information
10.11.2 Merck Introduction and Business Overview
10.11.3 Merck Respiratory Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Merck Respiratory Drug Products Offered
10.11.5 Merck Recent Development
10.12 Beximco
10.12.1 Beximco Company Information
10.12.2 Beximco Introduction and Business Overview
10.12.3 Beximco Respiratory Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Beximco Respiratory Drug Products Offered
10.12.5 Beximco Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Respiratory Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Respiratory Drug Industrial Chain Analysis
11.4 Respiratory Drug Market Dynamics
11.4.1 Respiratory Drug Industry Trends
11.4.2 Respiratory Drug Market Drivers
11.4.3 Respiratory Drug Market Challenges
11.4.4 Respiratory Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Respiratory Drug Distributors
12.3 Respiratory Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Inhalable & Nasal Spray
Table 2. Major Company of Oral
Table 3. Major Company of Others
Table 4. Global Respiratory Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Respiratory Drug Sales by Type (2018-2024) & (M Units)
Table 6. Global Respiratory Drug Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Respiratory Drug Sales by Type (2018-2024) & (US& Million)
Table 8. Global Respiratory Drug Market Share in Value by Type (2018-2024)
Table 9. Global Respiratory Drug Price by Type (2018-2024) & (US$/Unit)
Table 10. Global Respiratory Drug Sales by Type (2024-2034) & (M Units)
Table 11. Global Respiratory Drug Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Respiratory Drug Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Respiratory Drug Sales Market Share in Value by Type (2024-2034)
Table 14. Global Respiratory Drug Price by Type (2024-2034) & (US$/Unit)
Table 15. North America Respiratory Drug Sales by Type (2018-2024) & (M Units)
Table 16. North America Respiratory Drug Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Respiratory Drug Sales (M Units) by Type (2018-2024)
Table 18. Europe Respiratory Drug Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Respiratory Drug Sales (M Units) by Type (2018-2024)
Table 20. Asia-Pacific Respiratory Drug Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Respiratory Drug Sales (M Units) by Type (2018-2024)
Table 22. Latin America Respiratory Drug Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Respiratory Drug Sales (M Units) by Type (2018-2024)
Table 24. Middle East and Africa Respiratory Drug Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Respiratory Drug Sales by Company (2018-2024) & (M Units)
Table 26. Global Respiratory Drug Sales Share by Company (2018-2024)
Table 27. Global Respiratory Drug Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Respiratory Drug Revenue Share by Company (2018-2024)
Table 29. Global Market Respiratory Drug Price by Company (2018-2024) & (US$/Unit)
Table 30. Global Respiratory Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Respiratory Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Respiratory Drug as of 2022)
Table 33. Date of Key Manufacturers Enter into Respiratory Drug Market
Table 34. Key Manufacturers Respiratory Drug Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Respiratory Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Respiratory Drug Sales by Region (2018-2024) & (M Units)
Table 38. Global Respiratory Drug Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Respiratory Drug Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Respiratory Drug Sales Market Share in Value by Region (2018-2024)
Table 41. Global Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 42. Global Respiratory Drug Sales by Region (2024-2034) & (M Units)
Table 43. Global Respiratory Drug Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Respiratory Drug Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Respiratory Drug Sales Market Share in Value by Region (2024-2034)
Table 46. Global Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 47. Global Respiratory Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Respiratory Drug Sales by Application (2018-2024) & (M Units)
Table 49. Global Respiratory Drug Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Respiratory Drug Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Respiratory Drug Sales Market Share in Value by Application (2018-2024)
Table 52. Global Respiratory Drug Price by Application (2018-2024) & (US$/Unit)
Table 53. Global Respiratory Drug Sales by Application (2024-2034) & (M Units)
Table 54. Global Respiratory Drug Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Respiratory Drug Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Respiratory Drug Sales Market Share in Value by Application (2024-2034)
Table 57. Global Respiratory Drug Price by Application (2024-2034) & (US$/Unit)
Table 58. North America Respiratory Drug Sales by Application (2018-2024) (M Units)
Table 59. North America Respiratory Drug Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Respiratory Drug Sales by Application (2018-2024) (M Units)
Table 61. Europe Respiratory Drug Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Respiratory Drug Sales by Application (2018-2024) (M Units)
Table 63. Asia-Pacific Respiratory Drug Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Respiratory Drug Sales by Application (2018-2024) (M Units)
Table 65. Latin America Respiratory Drug Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Respiratory Drug Sales by Application (2018-2024) (M Units)
Table 67. Middle East and Africa Respiratory Drug Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Respiratory Drug Sales by Country (2018-2024) & (M Units)
Table 69. North America Respiratory Drug Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Respiratory Drug Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Respiratory Drug Sales Market Share in Value by Country (2018-2024)
Table 72. North America Respiratory Drug Sales by Country (2024-2034) & (M Units)
Table 73. North America Respiratory Drug Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Respiratory Drug Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Respiratory Drug Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Respiratory Drug Sales by Country (2018-2024) & (M Units)
Table 77. Europe Respiratory Drug Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Respiratory Drug Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Respiratory Drug Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Respiratory Drug Sales by Country (2024-2034) & (M Units)
Table 81. Europe Respiratory Drug Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Respiratory Drug Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Respiratory Drug Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Respiratory Drug Sales by Region (2018-2024) & (M Units)
Table 85. Asia-Pacific Respiratory Drug Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Respiratory Drug Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Respiratory Drug Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Respiratory Drug Sales by Region (2024-2034) & (M Units)
Table 89. Asia-Pacific Respiratory Drug Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Respiratory Drug Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Respiratory Drug Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Respiratory Drug Sales by Country (2018-2024) & (M Units)
Table 93. Latin America Respiratory Drug Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Respiratory Drug Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Respiratory Drug Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Respiratory Drug Sales by Country (2024-2034) & (M Units)
Table 97. Latin America Respiratory Drug Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Respiratory Drug Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Respiratory Drug Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Respiratory Drug Sales by Country (2018-2024) & (M Units)
Table 101. Middle East and Africa Respiratory Drug Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Respiratory Drug Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Respiratory Drug Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Respiratory Drug Sales by Country (2024-2034) & (M Units)
Table 105. Middle East and Africa Respiratory Drug Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Respiratory Drug Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Respiratory Drug Sales Market Share in Value by Country (2024-2034)
Table 108. GSK Company Information
Table 109. GSK Introduction and Business Overview
Table 110. GSK Respiratory Drug Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. GSK Respiratory Drug Product
Table 112. GSK Recent Development
Table 113. AstraZeneca Company Information
Table 114. AstraZeneca Introduction and Business Overview
Table 115. AstraZeneca Respiratory Drug Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. AstraZeneca Respiratory Drug Product
Table 117. AstraZeneca Recent Development
Table 118. Boehringer Ingelheim Company Information
Table 119. Boehringer Ingelheim Introduction and Business Overview
Table 120. Boehringer Ingelheim Respiratory Drug Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Boehringer Ingelheim Respiratory Drug Product
Table 122. Boehringer Ingelheim Recent Development
Table 123. Vertex Company Information
Table 124. Vertex Introduction and Business Overview
Table 125. Vertex Respiratory Drug Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. Vertex Respiratory Drug Product
Table 127. Vertex Recent Development
Table 128. Roche Company Information
Table 129. Roche Introduction and Business Overview
Table 130. Roche Respiratory Drug Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Roche Respiratory Drug Product
Table 132. Roche Recent Development
Table 133. Novartis Company Information
Table 134. Novartis Introduction and Business Overview
Table 135. Novartis Respiratory Drug Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Novartis Respiratory Drug Product
Table 137. Novartis Recent Development
Table 138. Teva Company Information
Table 139. Teva Introduction and Business Overview
Table 140. Teva Respiratory Drug Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Teva Respiratory Drug Product
Table 142. Teva Recent Development
Table 143. Chiesi Company Information
Table 144. Chiesi Introduction and Business Overview
Table 145. Chiesi Respiratory Drug Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. Chiesi Respiratory Drug Product
Table 147. Chiesi Recent Development
Table 148. Mylan Company Information
Table 149. Mylan Introduction and Business Overview
Table 150. Mylan Respiratory Drug Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. Mylan Respiratory Drug Product
Table 152. Mylan Recent Development
Table 153. Sumitomo Dainippon Company Information
Table 154. Sumitomo Dainippon Introduction and Business Overview
Table 155. Sumitomo Dainippon Respiratory Drug Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. Sumitomo Dainippon Respiratory Drug Product
Table 157. Sumitomo Dainippon Recent Development
Table 158. Merck Company Information
Table 159. Merck Introduction and Business Overview
Table 160. Merck Respiratory Drug Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. Merck Respiratory Drug Product
Table 162. Merck Recent Development
Table 163. Beximco Company Information
Table 164. Beximco Introduction and Business Overview
Table 165. Beximco Respiratory Drug Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. Beximco Respiratory Drug Product
Table 167. Beximco Recent Development
Table 168. Key Raw Materials Lists
Table 169. Raw Materials Key Suppliers Lists
Table 170. Respiratory Drug Market Trends
Table 171. Respiratory Drug Market Drivers
Table 172. Respiratory Drug Market Challenges
Table 173. Respiratory Drug Market Restraints
Table 174. Respiratory Drug Distributors List
Table 175. Respiratory Drug Downstream Customers
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Respiratory Drug Product Picture
Figure 2. Global Respiratory Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Respiratory Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Respiratory Drug Sales Status and Outlook (2018-2034) & (M Units)
Figure 5. Product Picture of Inhalable & Nasal Spray
Figure 6. Global Inhalable & Nasal Spray Sales YoY Growth (2018-2034) & (M Units)
Figure 7. Product Picture of Oral
Figure 8. Global Oral Sales YoY Growth (2018-2034) & (M Units)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2018-2034) & (M Units)
Figure 11. Global Respiratory Drug Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Respiratory Drug Sales Market Share by Type in 2022 & 2034
Figure 13. North America Respiratory Drug Sales Market Share in Volume by Type in 2022
Figure 14. North America Respiratory Drug Sales Market Share in Value by Type in 2022
Figure 15. Europe Respiratory Drug Sales Market Share in Volume by Type in 2022
Figure 16. Europe Respiratory Drug Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Respiratory Drug Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Respiratory Drug Sales Market Share in Value by Type in 2022
Figure 19. Latin America Respiratory Drug Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Respiratory Drug Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Respiratory Drug Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Respiratory Drug Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Respiratory Drug Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Respiratory Drug Revenue in 2022
Figure 25. Respiratory Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Hospital
Figure 27. Global Hospital Sales YoY Growth (2018-2034) & (M Units)
Figure 28. Product Picture of Drugs Store
Figure 29. Global Drugs Store Sales YoY Growth (2018-2034) & (M Units)
Figure 30. Global Respiratory Drug Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Respiratory Drug Sales Market Share by Application in 2022 & 2034
Figure 32. North America Respiratory Drug Sales Market Share in Volume by Application in 2022
Figure 33. North America Respiratory Drug Sales Market Share in Value by Application in 2022
Figure 34. Europe Respiratory Drug Sales Market Share in Volume by Application in 2022
Figure 35. Europe Respiratory Drug Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Respiratory Drug Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Respiratory Drug Sales Market Share in Value by Application in 2022
Figure 38. Latin America Respiratory Drug Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Respiratory Drug Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Respiratory Drug Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Respiratory Drug Manufacturing Cost Structure
Figure 43. Respiratory Drug Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries